02-10-2021 12:32 PM | Source: Reuters
India`s Biological E looking to make 600 million J&J vaccine shots a year: CEO
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
NEW DELHI - Indian pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.
"We are targeting 600 million doses for J&J," said Datla. "This will be in addition to our own product for which we are targeting approximately 1 billion doses."
(Reporting by Krishna N. Das; Editing by Euan Rocha)
Latest News
Buy ABB India Ltd For Target Rs.8,500 By Motilal Osw...
`The Sabarmati Report`: Vikrant Massey highlights fi...
Shraddha Kapoor, Varun Dhawan spotted in dazzling bl...
India aims for equity and balance when negotiating F...
Evening Roundup : A Daily Report on Bullion Energy &...
.jpg)
Mumbai: Actor Amitabh Bachchan greets fans outside h...
PM Narendra Modi receives traditional welcome in Rio...
Brazilian Vedic scholars chant `Vedic Mantras` to we...
Brazilian Vedic scholars to chant `Vedic Mantras` be...
Indian Diaspora excited, emotional and proud over PM...
